The bill would create a dedicated 'Director of Dementia Care and Coordination' position inside the Executive Office of Health ...

Explore the latest advancements in Alzheimer's treatment and the impact of new medications on patient independence and daily ...

A 75-year-old man with a genetic predisposition for Alzheimer’s has yet to show signs of the disease. Could this offer ...

Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Her husband ...

The reelection of Donald Trump was, in many ways, a correction. A correction for how the media and government have conducted ...

Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Her husband ...

In an exceptionally rare case, a patient with a high genetic risk of developing Alzheimer's appears to have avoided his ...

Minnesota wouldn’t be the first to create a position to manage dementia care in the state. Freeman estimates around 30 states ...

Alzheimer's disease has followed Doug Whitney around like a 'plague.' Mr Whitney, from Washington state, grew up with more than a dozen aunts and uncles, but 10 didn't make it to their 60th birthdays.

A new study has shown that two drugs - lecanemab and donanemab - could help patients stay independently by approximately 10–13 months in the early stage of Alzheimer's disease.

She worries about their side effects, especially the possibility they might raise her risk of dementia, but “I can’t sleep when I try to stop taking them,” she says. Conclusions are ...